A Minnesota mother has told how her 26-year-old diabetic son died because he could not afford insulin as the pharmaceutical industry hikes up prescription medications. 'The hardest part is every time I tell the story, it's like reality slaps me in my face that my son is no longer here,' Smith-Holt told CBS News. Alec was a Type 1 diabetic required to take insulin every day to live. His attempts at rationing led to him entering a diabetic coma alone in his apartment where he died. and the Minnesota attorney general alleges insulin makers set higher 'phony' list prices to offer bigger rebates to PBMs while keeping profit margins high.

Source: Daily Mail January 04, 2019 19:30 UTC